13F filerCIK 1061768 ↗

Baupost Group

You are looking at Q2 2020. See the latest, Q3 2026 →

Reported value

$8.01B

+18% on the quarter before

Positions

31

4 new, 6 sold out

Top 10

76.0%

of the value

Est. gain

+$2.05B

on stocks held all quarter

Est. return

+35.8%

on those stocks since Q1 2020

Filed

Aug 13, 2020

On SEC EDGAR ↗

Positions as of Jun 30, 2020, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q1 2020. Striped tiles are options.

Ebay Inc.21%
Liberty Global Plc15%
Fox Corp9.1%
Viasat Inc6.6%
Viacomcbs Inc5.5%
Qorvo4.2%
Translate Bio Inc4.0%
Hp Inc3.9%
Alphabet3.8%
Mckesson Corp3.2%
Hd Supply Hldgs Inc2.9%
Akebia Therapeutics Inc2.5%
Theravance Biopharma Inc2.4%
Meta2.4%
Nexstar Media Group Inc2.2%
Liberty Global Plc2.1%
Fox Corp1.9%
Atara Biotherapeutics Inc1.8%
7 others1.6%
Hca Healthcare Inc1.2%
0.8%
0.8%
0.6%
0.5%

Largest buys

Since Q1 2020, sized at quarter-end prices.

  1. Hca Healthcare Inc~$97.1MNew, 0.0% → 1.2% of the portfolio+1,000,000 shares
  2. Verint Sys Inc~$27.8MNew, 0.0% → 0.3% of the portfolio+616,328 shares
  3. Atara Biotherapeutics Inc~$23.5MAdded, 1.0% → 1.8% of the portfolio+1,613,130 shares
  4. Ventas Inc~$20.1MNew, 0.0% → 0.3% of the portfolio+550,000 shares
  5. Liberty Global Plc~$18.3MAdded, 12.5% → 14.6% of the portfolio+850,000 shares
  6. Hd Supply Hldgs Inc~$14.0MAdded, 2.6% → 2.9% of the portfolio+403,653 shares
  7. Translate Bio Inc~$8.8MAdded, 2.5% → 4.0% of the portfolio+500,000 shares
  8. Ss&C Technologies Hldgs Inc~$7.9MNew, 0.0% → 0.1% of the portfolio+140,516 shares
  9. Qorvo~$287,378Added, 3.6% → 4.2% of the portfolio+2,600 shares

Largest sells

Since Q1 2020, sized at quarter-end prices.

  1. Cheniere Energy Inc~$272.2MSold out, 4.0% → 0.0% of the portfolio−8,124,235 shares
  2. Meta~$257.2MCut, 4.9% → 2.4% of the portfolio−1,132,500 shares
  3. Alphabet~$121.3MCut, 5.2% → 3.8% of the portfolio−85,820 shares
  4. Viacomcbs Inc~$85.4MCut, 4.7% → 5.5% of the portfolio−3,662,415 shares
  5. Univar Solutions Inc~$71.1MCut, 0.9% → 0.3% of the portfolio−4,216,752 shares
  6. Colony Cap Inc New~$57.6MCut, 1.3% → 0.8% of the portfolio−24,000,000 shares
  7. Energy Transfer Lp~$55.7MSold out, 0.8% → 0.0% of the portfolio−12,105,005 shares
  8. Amerisourcebergen Corp~$47.2MCut, 1.2% → 0.6% of the portfolio−468,149 shares
  9. Pg&E Corp~$44.4MCut, 1.3% → 0.5% of the portfolio−5,000,000 shares
  10. Xpo Logistics Inc~$41.2MSold out, 0.6% → 0.0% of the portfolio−845,877 shares

Holdings

As of Jun 30, 2020; changes in shares since Mar 31, 2020.

Positions, sorted by share of the portfolio
HoldingValue
Ebay Inc.COM · shares 0% · price +74.5%21.0%$1.68B+$718.4M
Liberty Global PlcSHS CL C · shares +1.6% · price +36.9%14.6%$1.17B+$311.5M
Fox CorpCL A COM · shares 0% · price +13.5%9.1%$732.8M+$87.2M
Viasat IncCOM · shares 0% · price +6.8%6.6%$526.9M+$33.6M
Viacomcbs IncCL B · shares −16% · price +66.5%5.5%$439.3M+$175.4M
QorvoCOM · shares +0.08% · price +37.1%4.2%$338.8M+$91.6M
Translate Bio IncCOM · shares +2.8% · price +81.4%4.0%$319.1M+$139.2M
Hp IncCOM · shares −10.0% · price +0.4%3.9%$313.8M+$1.3M
AlphabetCAP STK CL C · shares −29% · price +21.6%3.8%$303.5M+$53.8M
Mckesson CorpCOM · shares 0% · price +13.4%3.2%$256.1M+$30.3M
Hd Supply Hldgs IncCOM · shares +6.5% · price +21.9%2.9%$229.4M+$38.7M
Akebia Therapeutics IncCOM · shares −14% · price +79.2%2.5%$203.7M+$90.0M
Theravance Biopharma IncCOM · shares 0% · price −9.2%2.4%$195.4M−$19.7M
MetaCL A · shares −57% · price +36.1%2.4%$193.3M+$51.3M
Nexstar Media Group IncCL A · shares 0% · price +45.0%2.2%$174.5M+$54.1M
Liberty Global PlcSHS CL A · shares 0% · price +32.4%2.1%$167.4M+$41.0M
Fox CorpCL B COM · shares 0% · price +17.3%1.9%$152.5M+$22.5M
Atara Biotherapeutics IncCOM · shares +19% · price +71.2%1.8%$144.6M+$50.4M
Hca Healthcare IncCOM · shares New1.2%$97.1M—
Colony Cap Inc NewCL A COM · shares −48% · price +37.1%0.77%$61.6M+$16.7M
Veritiv CorpCOM · shares 0% · price +115.8%0.75%$60.5M+$32.4M
Amerisourcebergen CorpCOM · shares −50% · price +13.9%0.59%$47.2M+$5.7M
Pg&E CorpCOM · shares −52% · price −1.3%0.52%$41.7M−$563,981
Theravance Biopharma IncNOTE 3.250%11/0 · shares 0% · price +1.7%0.36%$29.2M—
Verint Sys IncCOM · shares New0.35%$27.8M—
Total 31 positions100%$8.01B+$2.05B

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q1 2020 to Q2 2020: 26 stocks held throughout, up $2.05B (+35.8%).

  1. Ebay Inc.+$718.4M+74%
  2. Liberty Global Plc+$311.5M+37%
  3. Viacomcbs Inc+$175.4M+66%
  4. Translate Bio Inc+$139.2M+81%
  5. Qorvo+$91.6M+37%
  6. Pg&E Corp−$563,981−1%
  7. Theravance Biopharma Inc−$19.7M−9%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

Pick a quarter to see what the fund held then.

$20.00B$10.00B$0
Q1 2016Q3 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q3 2026$5.05B−7%SEC ↗
Q2 2026$5.42B+6%SEC ↗
Q1 2026$5.12B−3%SEC ↗
Q4 2025$5.28B+10%SEC ↗
Q3 2025$4.79B+16%SEC ↗
Q2 2025$4.13B+18%SEC ↗
Q1 2025$3.50B+2%SEC ↗
Q4 2024$3.43B−2%SEC ↗
Q3 2024$3.52B−3%SEC ↗
Q2 2024$3.63B−0%SEC ↗
Q1 2024$3.65B−20%SEC ↗
Q4 2023$4.59B−12%SEC ↗
Q3 2023$5.21B−7%SEC ↗
Q2 2023$5.61B−4%SEC ↗
Q1 2023$5.85B−5%SEC ↗
Q4 2022$6.13B+6%SEC ↗
Q3 2022$5.79B−14%SEC ↗
Q2 2022$6.77B−27%SEC ↗
Q1 2022$9.30B−8%SEC ↗
Q4 2021$10.13B−7%SEC ↗
Q3 2021$10.88B−12%SEC ↗
Q2 2021$12.33B−2%SEC ↗
Q1 2021$12.56B+16%SEC ↗
Q4 2020$10.84B+17%SEC ↗
Q3 2020$9.25B+15%SEC ↗
Q2 2020$8.01B+18%SEC ↗
Q1 2020$6.77B−25%SEC ↗
Q4 2019$9.06B+3%SEC ↗
Q3 2019$8.83B−20%SEC ↗
Q2 2019$11.05B−7%SEC ↗
Q1 2019$11.90B+3%SEC ↗
Q4 2018$11.52B−12%SEC ↗
Q3 2018$13.06B+14%SEC ↗
Q2 2018$11.44B+10%SEC ↗
Q1 2018$10.37B+3%SEC ↗
Q4 2017$10.11B+26%SEC ↗
Q3 2017$8.02B−8%SEC ↗
Q2 2017$8.75B+3%SEC ↗
Q1 2017$8.49B+11%SEC ↗
Q4 2016$7.67B+9%SEC ↗
Q3 2016$7.04B−4%SEC ↗
Q2 2016$7.37B+6%SEC ↗
Q1 2016$6.92BSEC ↗

Subscribe to TheInference for free